PROCEPT BioRobotics Corporation PRCT Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$95.57M-4.5% | -$91.41M+13.7% | -$105.9M-21.5% | -$87.15M-45.6% | ||
| $6.39M+22.1% | $5.23M+37.5% | $3.81M+34.0% | $2.84M-14.5% | ||
| $47.6M+49.5% | $31.84M+66.4% | $19.13M+85.1% | $10.34M+172% | ||
| —— | $840K— | —— | $0— | ||
| —— | $35.96M+8.6% | $33.1M+206% | $10.81M— | ||
| $15.07M-12.6% | $17.24M— | —— | $15.25M+149% | ||
| —— | —— | $5.79M+36.4% | $4.24M— | ||
| $1.1M-65.7% | $3.21M— | —— | $1.88M— | ||
| —— | $1.77M+254% | -$1.15M-143% | $2.66M— | ||
| $3.32M-10.7% | $3.72M+12.0% | $3.32M+81.3% | $1.83M+131% | ||
| -$157K— | $0— | $0+100% | -$3.26M— | ||
| $1.59M-65.8% | $4.65M— | —— | $6.97M+280% | ||
| -$48.99M+50.6% | -$99.21M+8.1% | -$108M-34.4% | -$80.38M-40.2% | ||
| $9.36M+112% | $4.41M-82.5% | $25.21M+850% | $2.65M+348% | ||
| -$9.36M-112% | -$4.41M+82.5% | -$25.21M-850% | -$2.65M-348% | ||
| $0-100% | $164.5M+0.7% | $163.42M— | $0— | ||
| $11.19M-93.8% | $180.13M+7.3% | $167.8M— | —— | ||
| -$74K— | —— | $0— | —— | ||
| -$47.22M-162% | $76.5M— | —— | -$79.42M-136% | ||
| $3.46M-12.8% | $3.97M-2.1% | $4.06M-5.5% | $4.29M-9.7% | ||
| $1.59M-65.8% | $4.65M— | —— | $6.97M+280% | ||
| $142K+6.0% | $134K+7.2% | $125K-83.5% | $757K-27.6% | ||
| $2.9M+69.9% | $1.7M+96.3% | $868K+1,602% | $51K— | ||
| $1.1M-65.7% | $3.21M— | —— | $1.88M— | ||
| $566K-69.9% | $1.88M+89.0% | $995K— | —— | ||
| $508K+32.6% | $383K— | —— | -$1.48M-528% | ||
| —— | $840K— | $0— | —— | ||
| —— | —— | —— | —— | ||
| -$74K— | —— | $0— | —— | ||
| —— | —— | —— | —— | ||
| $3.32M-10.7% | $3.72M+12.0% | $3.32M+81.3% | $1.83M+131% | ||
| -$58.34M+43.7% | -$103.62M+22.2% | -$133.21M-60.4% | -$83.04M-43.3% | ||
| -$58.34M+43.7% | -$103.62M+22.2% | -$133.21M-60.4% | -$83.04M-43.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does PROCEPT BioRobotics Corporation generate?
- PROCEPT BioRobotics Corporation (PRCT) generated -$70.1M in operating cash flow over the trailing twelve months.
- What is PROCEPT BioRobotics Corporation's free cash flow?
- After $10.4M of capital expenditures, PROCEPT BioRobotics Corporation's free cash flow was -$80.6M over the trailing twelve months, up 8.7% year over year.
- Where does PROCEPT BioRobotics Corporation's cash flow data come from?
- Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
